Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer. [electronic resource]
Producer: 20080702Description: 155-6 p. digitalISSN:- 0284-186X
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Fatal Outcome
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Lung Neoplasms -- secondary
- Male
- Middle Aged
- Tumor Lysis Syndrome -- etiology
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.